Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001413499 | SCV001615616 | likely benign | Neuroblastoma, susceptibility to, 3 | 2022-03-02 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002358923 | SCV002653157 | likely benign | Hereditary cancer-predisposing syndrome | 2020-11-23 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |